All In MedTech

FDA Clearance Tracker · P000058-S099

Infuse TM Bone Graft/Medtronic lnterbody Fusion Device

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 28, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 28, 2026

Approved

Time to decision

90 days

Received Apr 29, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000058-S099
Device name
Infuse TM Bone Graft/Medtronic lnterbody Fusion Device
Applicant location
Memphis, TN
Received
Apr 29, 2026
Decided
Jul 28, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P000058

Device type

Device class
Class III

Every decision under product code NEK

FDA's approval statement

As written in FDA's record.

Approval to offer an alternatively configured Infuse™ Bone Graft kit in which the sterile water for injection (sWFI) vials, syringes, and needles have been removed from the kit, as well as minor labeling changes associated with this alternative kit configuration.

Source documents

Other decisions for Medtronic Sofamor Danek USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.